Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health data.

Bibliographic Details
Title: Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health data.
Authors: Bidulka, Patrick, Lugo-Palacios, David G., Carroll, Orlagh, O'Neill, Stephen, Adler, Amanda I., Basu, Anirban, Silverwood, Richard J., Bartlett, Jonathan W., Nitsch, Dorothea, Charlton, Paul, Briggs, Andrew H., Smeeth, Liam, Douglas, Ian J., Khunti, Kamlesh, Grieve, Richard
Source: BMJ: British Medical Journal; 5/11/2024, Vol. 385 Issue 8428, p1-15, 15p
Subject Terms: METFORMIN, PEOPLE with diabetes, GLYCOSYLATED hemoglobin, BODY mass index, RESEARCH funding, ENZYME inhibitors, MAJOR adverse cardiovascular events, HYPOGLYCEMIC agents, ORAL drug administration, TREATMENT effectiveness, SULFONYLUREAS, DESCRIPTIVE statistics, LONGITUDINAL method, TYPE 2 diabetes, SODIUM-glucose cotransporter 2 inhibitors, COMPARATIVE studies, BLOOD pressure, CONFIDENCE intervals, PSYCHOSOCIAL factors, PHARMACODYNAMICS, EVALUATION
Database: Complementary Index
More Details
ISSN:17561833
DOI:10.1136/bmj-2023-077097
Published in:BMJ: British Medical Journal
Language:English